Walleye Capital LLC Phathom Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.99 - $10.71 $816,306 - $1.25 Million
116,782 Added 136.79%
202,154 $1.85 Million
Q3 2023

Nov 14, 2023
BUY
$10.26 - $15.7 $875,916 - $1.34 Million
85,372 New
85,372 $885,000
Q4 2022

Feb 14, 2023
BUY
$9.18 - $11.53 $1.34 Million - $1.68 Million
145,870 New
145,870 $1.64 Million
Q2 2022

Aug 08, 2022
BUY
$6.2 - $15.5 $514,792 - $1.29 Million
83,031 New
83,031 $701,000

Others Institutions Holding PHAT

# of Institutions
143
Shares Held
74.8M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $272M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email